Skip to content
Open access

Machine learning–derived intracellular protein–based prognostic model reflecting a senescence-associated secretory phenotype-driven immunosuppressive microenvironment in lung adenocarcinoma

Oct 2026 · PeerJ · Vol 14 · 0 citations · 46 references
Medicine

TL;DR

It is suggested that SASP-related gene-expression patterns are associated with LUAD molecular subtypes, senescence signaling, computationally inferred immune features, and treatment-related outcomes and may serve as a potential biomarker for prognostic stratification in LUAD.

Abstract

Background This study aimed to investigate the associations of senescence-associated secretory phenotype (SASP)-related genes with the tumor immune microenvironment (TIME) and clinical outcomes in lung adenocarcinoma (LUAD) and to develop and evaluate a prognostic signature for risk stratification and exploratory treatment-response prediction. Methods Non-negative matrix factorization (NMF) was conducted to identify distinct molecular subtypes. Least absolute shrinkage and selection operator (LASSO), Random Forest, and extreme gradient boosting (XGBoost) were utilized to identify core prognostic SASP genes. The expression patterns of selected SASP-related genes were explored using multi-omics datasets, LUAD cell lines, and clinical specimens. Results Cluster 1 was associated with significantly shorter overall survival (OS), enhanced senescence pathway activity, and computationally inferred immunosuppressive and immune-exclusion features. Five intracellular SASP regulators—ANGPTL4, CDKN2A, H2AX, MMP1, and CCL20—were selected through machine learning to construct the SASP Protein Regulator Score (SASP-PRS). A high SASP-PRS was associated with the activation of senescence/SASP and cell-cycle pathways, suppression of antitumor immune signatures, and distinct immune-checkpoint and chemokine expression profiles. A higher SASP-PRS was also associated with advanced disease stage, poorer OS, predicted lower responsiveness to immunotherapy, lower predicted sensitivity to erlotinib, and higher predicted sensitivity to selected chemotherapeutic agents. The nomogram incorporating the SASP-PRS demonstrated discriminatory ability and calibration for predicting 1-, 3-, and 5-year OS in the analyzed LUAD cohorts. Conclusion These findings suggest that SASP-related gene-expression patterns are associated with LUAD molecular subtypes, senescence signaling, computationally inferred immune features, and treatment-related outcomes. The SASP-PRS may serve as a potential biomarker for prognostic stratification in LUAD. However, its utility for treatment-response assessment remains exploratory. Prospective external validation and functional studies are required to establish its clinical applicability and clarify the mechanisms linking SASP-related networks to the LUAD immune microenvironment.

Read PDF

Similar papers

Open access Sep 2026

Integrative identification and preliminary validation of senescence-associated secretory phenotype-related candidate biomarkers in type 2 diabetes

Senescence-associated secretory phenotype (SASP)-related inflammatory programs have been implicated in type 2 diabetes mellitus (T2DM), yet blood-based candidates have not been systematically screened and validated across independent cohorts. We adopted standardized senescence signature scoring and multi-cohort indepen...

Bing-Lian Liu, Jia-Meng Jia, Nan Wang et al. · 0 citations
Open access Oct 2026

Identification of Macrophage Polarization-Related Biomarkers in Multiple Myeloma Using Integrated Bioinformatics.

These findings identify eight MP-related hub genes as candidate prognostic biomarkers and provide a risk model with acceptable predictive performance, offering insights into the immune-metabolic interplay in MM and suggesting potential avenues for personalized therapeutic strategies.

Ran Wang, Jing-Wei Zhang, Jing Qi et al. · 0 citations
Open access Oct 2026

An AI-derived inflammation-metabolism ecosystem signature reveals ATP2A2 as a microenvironment-remodeling driver of immune evasion in lung adenocarcinoma

Background Chronic inflammation and metabolic dysregulation are increasingly recognized as interconnected drivers of tumorigenesis and immune evasion, yet their combined prognostic and mechanistic relevance in lung adenocarcinoma (LUAD) remains poorly defined. Methods A curated 117-gene set representing systemic inflam...

Xiu-Juan Hu, Guo-Xin Zhang, Yue Zhang et al. · 0 citations
Open access Sep 2026

Dual molecular and clinical machine-learning prognostic modeling in pancreatic ductal adenocarcinoma: a chaperone-mediated autophagy–based framework integrating multi-cohort molecular signatures and a single-center clinical nomogram

This study identified CMA-related cellular heterogeneity, established a molecular prognostic model that retained prognostic discrimination in two independent validation cohorts, demonstrated the functional relevance of KRT19, and developed an independent clinical prediction tool.

Qing-Yan Kou, Sheng-Qian Qiao, Zhen-Yuan Liu et al. · 0 citations
Open access Oct 2026

Development and External Validation of an M2 Macrophage–Related Prognostic Signature in Breast Cancer Using Multi-Omics Data and Machine Learning

A 16-gene M2 macrophage–related signature (M2MMS) was identified that stratified patients into subgroups with distinct survival outcomes in both cohorts and provides a basis for risk stratification and mechanistic investigation.

Yan-Zhan Liu, Ye-Long Liu, Hong-Yan Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.